Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the completion of the transaction, the insider directly owned 10,457 shares in the company, valued at $2,836,252.11. This trade represents a 22.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Plexus Trading Down 1.0%
NASDAQ PLXS opened at $261.91 on Thursday. Plexus Corp. has a 1-year low of $115.35 and a 1-year high of $275.83. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $7.01 billion, a PE ratio of 38.29 and a beta of 0.88. The firm’s fifty day simple moving average is $221.05 and its 200-day simple moving average is $184.74.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the prior year, the business posted $1.66 earnings per share. Plexus’s revenue for the quarter was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, sell-side analysts anticipate that Plexus Corp. will post 6.23 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Plexus
Analyst Ratings Changes
PLXS has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Benchmark reiterated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a report on Monday, March 16th. Weiss Ratings upgraded shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday. Needham & Company LLC upped their price objective on shares of Plexus from $206.00 to $285.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Finally, Stifel Nicolaus set a $250.00 price objective on shares of Plexus and gave the stock a “buy” rating in a report on Monday, April 20th. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $229.17.
View Our Latest Stock Analysis on Plexus
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
